Eolas Therapeutics, Inc.

États‑Unis d’Amérique

Commandez votre montre hebdomadaire Eolas Therapeutics, Inc.
Quantité totale PI 13
Rang # Quantité totale PI 119 438
Note d'activité PI 1,4/5.0    5
Rang # Activité PI 197 852

Brevets

Marques

8 0
1 0
4 0
0
 
Dernier brevet 2024 - Halo-substituted piperidines as ...
Premier brevet 2013 - Substituted prolines / piperidin...

Derniers inventions, produits et services

2024 Invention Halo-substituted piperidines as orexin receptor modulators. The present application relates to c...
2022 Invention Halo-substituted piperidines as orexin receptor modulators. The present application relates to ce...
2017 Invention Halo-substituted piperidines as orexin receptor modulators.
The present application re...
2016 Invention Substituted prolines/piperidines as orexin receptor antagonists. 2, or both; to pharmaceutical co...
2015 Invention Difluoropyrrolidines as orexin receptor modulators. The present application relates to certain di...
Invention Substituted prolines / piperidines as orexin receptor antagonists. The present invention is direc...
2014 Invention Substituted prolines / piperidines as orexin receptor antagonists. 2, or both; to pharmaceutical ...